Blavatnik Biomedical Overview

  • Investor Type
  • Accelerator/​Incubator

  • Status
  • Active

  • Investments
  • 2

  • Portfolio
  • 1

  • Exits
  • 1


Blavatnik Biomedical General Information


Blavatnik Biomedical is an accelerator that bridges the gap between innovative, early-stage life science research and successful development of high-impact biomedical products. The firm's integrated approach combines essential funding with development and business expertise, leading to commercial partnerships that bring forth new biomedical discoveries that create value and benefit society.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Primary Office
  • 1350 Massachusetts Avenue
  • Cambridge, MA 02138
  • United States
+1 (617) 000-0000

Blavatnik Biomedical Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
StemCellerant 08-Jun-2017 Accelerator/Incubator Other Pharmaceuticals and Biotechnology Generating Revenue
000000 00000000000 000000000000 Drug Discovery Generating Revenue
To view Blavatnik Biomedical’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blavatnik Biomedical Exits (1)

Company Name Exit Date Exit Type Exit Size
000000 00000000000 01-Apr-2021 000000000000000000 000.00
To view Blavatnik Biomedical’s complete exits history, request access »

Blavatnik Biomedical Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial